B1 Non-refereed article in a scientific journal
TP53 mutations confer resistance to hypomethylating agents and BCL-2 inhibition in myeloid neoplasms
Authors: Schimmer Roman R, Kovtonyuk Larisa V, Klemm Nancy, Fullin Jonas, Stolz Sebastian M, Mueller Jan, Caiado Francisco, Kurppa Kari J, Ebert Benjamin L, Manz Markus G, Boettcher Steffen
Publisher: Elsevier
Publication year: 2022
Journal: Blood Advances
Journal name in source: BLOOD ADVANCES
Journal acronym: BLOOD ADV
Volume: 6
Issue: 11
First page : 3201
Last page: 3206
Number of pages: 6
eISSN: 2473-9537
DOI: https://doi.org/10.1182/bloodadvances.2021005859
Publication's open availability at the time of reporting: Open Access
Publication channel's open availability : Partially Open Access publication channel
Web address : https://doi.org/10.1182/bloodadvances.2021005859
Self-archived copy’s web address: https://research.utu.fi/converis/portal/detail/Publication/176305725
Downloadable publication This is an electronic reprint of the original article. |  |
